‘Game changer’ experimental drug doubles survival time for pancreatic cancer, trial shows

[ad_1] An experimental drug that doubles survival time for pancreatic cancer is being hailed as a breakthrough for combating one of the world’s deadliest cancers. A Phase 3, 500-person trial pitted the once-a-day pill against standard chemotherapy in patients who…







